BioMaxima S.A. (WSE:BMX)
Poland · Delayed Price · Currency is PLN 12.85
+0.05 (0.39%)
At close: Feb 5, 2026
BioMaxima Market Cap
BioMaxima has a market cap or net worth of 53.88 million as of February 5, 2026. Its market cap has increased by 9.83% in one year.
Market Cap
53.88M
Enterprise Value
68.74M
Revenue
59.11M
Ranking
n/a
PE Ratio
85.67
Stock Price
12.85
Market Cap Chart
Since July 21, 2010, BioMaxima's market cap has increased from 11.40M to 53.88M, an increase of 372.49%. That is a compound annual growth rate of 10.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 53.67M | 6.22% |
| Dec 30, 2025 | 50.53M | 12.62% |
| Dec 30, 2024 | 44.87M | -34.84% |
| Dec 29, 2023 | 68.85M | -35.28% |
| Dec 30, 2022 | 106.38M | -6.37% |
| Dec 30, 2021 | 113.62M | -4.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.07B |
| NEUCA | 3.50B |
| Synektik Spólka Akcyjna | 2.50B |
| Voxel | 1.45B |
| Urteste | 80.63M |
| Genomtec | 72.31M |
| Read-Gene | 71.21M |
| Sygnis | 56.50M |